The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801

G. Rammes, B. Mahal, J. Putzke, C. Parsons, P. Spielmanns, E. Pestel, R. Spanagel, W. Zieglgänsberger, J. Schadrack

Research output: Contribution to journalArticlepeer-review

141 Scopus citations

Fingerprint

Dive into the research topics of 'The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science